Yanan Zhu
Stock Analyst at Wells Fargo
(0)
# 4822
Out of 5,270 analysts
79
Total ratings
19.15%
Success rate
-25.60%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
uniQure | Maintains: Equal-Weight | 35 30 | 10.89 | 175.48% | 2 | Feb 28, 2025 | |
Intellia Therapeutic... | Maintains: Overweight | 60 50 | 9.45 | 429.1% | 4 | Feb 28, 2025 | |
bluebird bio | Maintains: Equal-Weight | 40 5 | 3.9 | 28.21% | 8 | Feb 24, 2025 | |
Affimed | Maintains: Overweight | 20 15 | 0.98 | 1430.61% | 6 | Dec 12, 2024 | |
Editas Medicine | Downgrades: Equal-Weight | 7 4 | 1.77 | 125.99% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 17 4 | 1.05 | 280.95% | 4 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 82 77 | 32.54 | 136.63% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 35 40 | 17.88 | 123.71% | 2 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 70 65 | 42.26 | 53.81% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 5.85 | 412.82% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 45 58 | 15.72 | 268.96% | 5 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 25 | 1.85 | 1251.35% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 25 | 4.03 | 520.35% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 50 50 | 29.2 | 71.23% | 3 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 9 14 | 3.9 | 258.97% | 1 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 10 | n/a | n/a | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | 1.01 | 395.05% | 2 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 13 | n/a | n/a | 3 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 4 | 0.92 | 334.78% | 3 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 24 | n/a | n/a | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 450 | n/a | n/a | 1 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 8 | 1.74 | 359.77% | 1 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 125 105 | 25.08 | 318.66% | 2 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 10 | 1.6 | 525% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 3 | 0.52 | 476.92% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1 1 | n/a | n/a | 2 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 272 326 | 622.66 | -47.64% | 1 | Feb 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 79 70 | n/a | n/a | 2 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 48 53 | n/a | n/a | 2 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 122 133 | n/a | n/a | 4 | May 7, 2020 |